Baird Financial Group Inc. Sells 5,319 Shares of Stryker Corporation $SYK

Key Points

• Baird Financial Group reduced its Stryker holdings by 1.4%, selling 5,319 shares and retaining 376,287 shares valued at approximately $118.5 million. Institutional investors collectively own 77.09% of the company.
• Stryker reported quarterly EPS of $3.69, beating estimates of $3.49, while revenue rose 9.4% year over year to $6.59 billion. The company declared a quarterly dividend of $0.88, equivalent to a 1.3% annual yield.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $386.28, despite recent target reductions. Director Ronda E. Stryker and other insiders sold more than $118 million of stock over the past 90 days.

Baird Financial Group Inc. cut its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 1.4% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 376,287 shares of the medical technology company's stock after selling 5,319 shares during the quarter. Baird Financial Group Inc. owned 0.10% of Stryker worth $118,470,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. California State Teachers Retirement System increased its holdings in shares of Stryker by 30,523.4% in the second quarter. California State Teachers Retirement System now owns 163,395,348 shares of the medical technology company's stock worth $51,443,391,000 after buying an additional 162,861,784 shares during the period. State Street Corp raised its holdings in Stryker by 2.1% during the 4th quarter. State Street Corp now owns 15,254,407 shares of the medical technology company's stock valued at $5,374,731,000 after buying an additional 311,507 shares during the last quarter. Wellington Management Group LLP raised its position in Stryker by 0.6% during the 2nd quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company's stock valued at $2,571,357,000 after purchasing an additional 45,478 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Stryker by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company's stock worth $2,636,238,000 after buying an additional 69,851 shares during the period. Finally, Norges Bank bought a new stake in shares of Stryker in the 4th quarter worth approximately $1,822,272,000. Hedge funds and other institutional investors own 77.09% of the company's stock.

Stryker Price Performance

Shares of NYSE:SYK opened at $276.16 on Wednesday. The business has a fifty day moving average price of $327.52 and a 200-day moving average price of $328.30. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. The company has a market capitalization of $105.93 billion, a PE ratio of 28.62, a PEG ratio of 1.90 and a beta of 0.76. Stryker Corporation has a 1-year low of $275.10 and a 1-year high of $395.90.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.49 by $0.20. The company had revenue of $6.59 billion for the quarter, compared to analysts' expectations of $6.58 billion. Stryker had a net margin of 14.43% and a return on equity of 23.63%. Stryker's revenue was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts expect that Stryker Corporation will post 15.03 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.3%. Stryker's payout ratio is currently 36.48%.

Analysts Set New Price Targets

A number of equities analysts recently commented on SYK shares. Weiss Ratings restated a "hold (c)" rating on shares of Stryker in a report on Friday, July 31st. Piper Sandler reduced their price target on shares of Stryker from $420.00 to $390.00 and set an "overweight" rating on the stock in a research report on Friday, July 31st. Wall Street Zen raised Stryker from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Citigroup reiterated a "buy" rating on shares of Stryker in a report on Thursday, August 13th. Finally, Royal Bank Of Canada decreased their target price on Stryker from $435.00 to $420.00 and set an "outperform" rating for the company in a research report on Friday, July 31st. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $386.28.

Insider Activity

In other Stryker news, Director Ronda E. Stryker sold 300,000 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares in the company, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Debra King sold 826 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider directly owned 6,210 shares in the company, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 351,267 shares of company stock valued at $118,197,701 over the last ninety days. 4.60% of the stock is currently owned by corporate insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker's principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.